AnaptysBio
ANAB
ANAB
147 hedge funds and large institutions have $816M invested in AnaptysBio in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 45 increasing their positions, 55 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
147
Holders Change
-6
Holders Change %
-3.92%
% of All Funds
1.97%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
27
Increased
45
Reduced
55
Closed
31
Calls
$5.28M
Puts
$2.89M
Net Calls
+$2.39M
Net Calls Change
+$1.83M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$30.3M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$17.4M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$7.81M |
| 4 |
6CM
683 Capital Management
New York
|
+$6.76M |
| 5 |
NL
Nuveen LLC
Charlotte,
North Carolina
|
+$5.94M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$40.7M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$24.3M |
| 3 |
BCM
Boxer Capital Management
San Diego,
California
|
-$24.2M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$13.9M |
| 5 |
BlackRock
New York
|
-$8.65M |
